| Application no. and date | 06772448.4 (espacenet) (Federated) (European Patent Register), 20060607 | | Patent/reg. no. and date | DK/EP 1924574, 20101110 | | Publication date | 20080528 | | Priority no. and date | US 688977 P, 20050609, US 705590 P, 20050804 | | EP pub. no. and date |
EP 1924574 20080528 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 140541 | | Inventor | MCKENNA, Joseph, 1237 Seifert Road
Nazareth, Pennsylvania 18064, US,
SHIEH, Wen-Chung, 295 Timber Drive
Berkeley Heights, New Jersey 07922, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | C07D 401/04 (2006.01) | | Title | Fremgangsmåde til syntese af 5-(methyl-1H-imidazol-1-yl)-3-(trifluormethyl)-benzenamin | | Int. application no. | US2006022155 | | Int. publication no. | WO2006135641 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
